Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
3.240
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $4.88 million. The enterprise value is -$4.94 million.
Market Cap | 4.88M |
Enterprise Value | -4.94M |
Important Dates
The next estimated earnings date is Wednesday, November 20, 2024, after market close.
Earnings Date | Nov 20, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GLMD has 1.51 million shares outstanding. The number of shares has increased by 189.80% in one year.
Shares Outstanding | 1.51M |
Shares Change (YoY) | +189.80% |
Shares Change (QoQ) | +15.27% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 2.32% |
Float | 1.49M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.15 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.48
Current Ratio | 6.48 |
Quick Ratio | 6.41 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.67% and return on invested capital (ROIC) is -34.92%.
Return on Equity (ROE) | -52.67% |
Return on Assets (ROA) | -29.31% |
Return on Capital (ROIC) | -34.92% |
Revenue Per Employee | n/a |
Profits Per Employee | -$735,375 |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.50% in the last 52 weeks. The beta is 0.80, so GLMD's price volatility has been lower than the market average.
Beta (5Y) | 0.80 |
52-Week Price Change | -32.50% |
50-Day Moving Average | 4.76 |
200-Day Moving Average | 4.33 |
Relative Strength Index (RSI) | 40.01 |
Average Volume (20 Days) | 149,845 |
Short Selling Information
Short Interest | 26,345 |
Short Previous Month | 34,164 |
Short % of Shares Out | 1.77% |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -6.24M |
Pretax Income | -6.36M |
Net Income | -5.88M |
EBITDA | -6.15M |
EBIT | -6.24M |
Earnings Per Share (EPS) | -$14.53 |
Balance Sheet
Cash & Cash Equivalents | 9.82M |
Total Debt | n/a |
Net Cash | 9.82M |
Net Cash Per Share | $6.52 |
Equity (Book Value) | 11.79M |
Book Value Per Share | 22.24 |
Working Capital | 8.52M |
Cash Flow
Operating Cash Flow | -5.92M |
Capital Expenditures | n/a |
Free Cash Flow | -5.92M |
FCF Per Share | -$3.93 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -189.80% |
Shareholder Yield | -189.80% |
Earnings Yield | -120.49% |
FCF Yield | -121.29% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 30, 2024. It was a reverse split with a ratio of 0.0833333:1.
Last Split Date | Aug 30, 2024 |
Split Type | Reverse |
Split Ratio | 0.0833333:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |